Back to Royce & Associates LP Royce & Associates LP

VVOS

4 quarters

Position history for Royce & Associates LPRoyce & Associates LP's holdings in Vivos Therapeutics, Inc.

No. Royce & Associates exited its VVOS (Vivos Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 348,000 shares worth $1.7M. Royce & Associates first reported VVOS in Q4 2020 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.8M

Total Shares Change

-300,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%$101.00
0
2021-Q2
Unchanged
348,000
0.0%
$1.7M0.0%$123.75
0
2021-Q1
Increased
348,000
+16.0%
$2.3M0.0%$166.00
30
2020-Q4
New
300,000
-
$1.8M0.0%$147.75
36

Other major holders of VVOS: Russell Investments Group, Ltd., Walleye Capital LLC, Two Sigma Investments, LP, Geode Capital Management, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used